102 related articles for article (PubMed ID: 29115438)
1. Astragaloside IV attenuates penicillin-induced epilepsy via inhibiting activation of the MAPK signaling pathway.
Zhu X; Chen Y; Du Y; Wan Q; Xu Y; Wu J
Mol Med Rep; 2018 Jan; 17(1):643-647. PubMed ID: 29115438
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV inhibits isoprenaline‑induced cardiac fibrosis by targeting the reactive oxygen species/mitogen‑activated protein kinase signaling axis.
Dai H; Jia G; Lu M; Liang C; Wang Y; Wang H
Mol Med Rep; 2017 Apr; 15(4):1765-1770. PubMed ID: 28260010
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV downregulates the expression of MDR1 in Bel‑7402/FU human hepatic cancer cells by inhibiting the JNK/c‑Jun/AP‑1 signaling pathway.
Wang PP; Luan JJ; Xu WK; Wang L; Xu DJ; Yang CY; Zhu YH; Wang YQ
Mol Med Rep; 2017 Sep; 16(3):2761-2766. PubMed ID: 28713943
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV suppresses inflammatory mediator production in synoviocytes and collagen‑induced arthritic rats.
Xu H; Wang CY; Zhang HN; Lv CY; Wang YZ
Mol Med Rep; 2016 Apr; 13(4):3289-96. PubMed ID: 26936538
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.
Xu C; Tang F; Lu M; Yang J; Han R; Mei M; Hu J; Zhou M; Wang H
Int Immunopharmacol; 2016 Apr; 33():119-27. PubMed ID: 26903414
[TBL] [Abstract][Full Text] [Related]
6. Immune regulation mechanism of Astragaloside IV on RAW264.7 cells through activating the NF-κB/MAPK signaling pathway.
Li Y; Meng T; Hao N; Tao H; Zou S; Li M; Ming P; Ding H; Dong J; Feng S; Li J; Wang X; Wu J
Int Immunopharmacol; 2017 Aug; 49():38-49. PubMed ID: 28550733
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocin‑induced diabetic rat model.
He KQ; Li WZ; Chai XQ; Yin YY; Jiang Y; Li WP
Int J Mol Med; 2018 Feb; 41(2):1078-1088. PubMed ID: 29207011
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NF‑κB pathway under high glucose conditions.
Sun L; Li W; Li W; Xiong L; Li G; Ma R
Int J Mol Med; 2014 Jul; 34(1):167-76. PubMed ID: 24718766
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway.
Li X; Wang X; Han C; Wang X; Xing G; Zhou L; Li G; Niu Y
Free Radic Biol Med; 2013 Jul; 60():168-76. PubMed ID: 23459070
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV prevents high glucose‑induced cell apoptosis and inflammatory reactions through inhibition of the JNK pathway in human umbilical vein endothelial cells.
You L; Fang Z; Shen G; Wang Q; He Y; Ye S; Wang L; Hu M; Lin Y; Liu M; Jiang A
Mol Med Rep; 2019 Mar; 19(3):1603-1612. PubMed ID: 30628687
[TBL] [Abstract][Full Text] [Related]
11. Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury.
Wang D; Liu Y; Zhong G; Wang Y; Zhang T; Zhao Z; Yan X; Liu Q
J Ethnopharmacol; 2017 May; 204():67-76. PubMed ID: 28389356
[TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB.
Qiu L; Yin G; Cheng L; Fan Y; Xiao W; Yu G; Xing M; Jia R; Sun R; Ma X; Hu G; Wang X; Tang M; Zhao Y
Int J Mol Med; 2015 Mar; 35(3):625-36. PubMed ID: 25604657
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
14. Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration.
Sun R; Zhang A; Ge Y; Gou J; Yin T; He H; Wang Y; Zhang G; Kong J; Shang L; Tao X; Zhang Y; Tang X
Expert Opin Drug Deliv; 2020 Sep; 17(9):1305-1320. PubMed ID: 32538226
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation.
Mei M; Tang F; Lu M; He X; Wang H; Hou X; Hu J; Xu C; Han R
Environ Toxicol Pharmacol; 2015 Nov; 40(3):764-73. PubMed ID: 26433482
[TBL] [Abstract][Full Text] [Related]
16. Propofol Inhibits Lipopolysaccharide-Induced Inflammatory Responses in Spinal Astrocytes via the Toll-Like Receptor 4/MyD88-Dependent Nuclear Factor-κB, Extracellular Signal-Regulated Protein Kinases1/2, and p38 Mitogen-Activated Protein Kinase Pathways.
Zhou CH; Zhu YZ; Zhao PP; Xu CM; Zhang MX; Huang H; Li J; Liu L; Wu YQ
Anesth Analg; 2015 Jun; 120(6):1361-8. PubMed ID: 25695672
[TBL] [Abstract][Full Text] [Related]
17. Effect of astragaloside IV against rat myocardial cell apoptosis induced by oxidative stress via mitochondrial ATP-sensitive potassium channels.
Guan FY; Yang SJ; Liu J; Yang SR
Mol Med Rep; 2015 Jul; 12(1):371-6. PubMed ID: 25739067
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6.
Yao XM; Liu YJ; Wang YM; Wang H; Zhu BB; Liang YP; Yao WG; Yu H; Wang NS; Zhang XM; Peng W
Mol Med Rep; 2016 Jun; 13(6):5149-56. PubMed ID: 27109610
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol attenuates hydrogen peroxide‑induced apoptosis, reactive oxygen species generation, and PSGL‑1 and VWF activation in human umbilical vein endothelial cells, potentially via MAPK signalling pathways.
Lou Z; Li X; Zhao X; Du K; Li X; Wang B
Mol Med Rep; 2018 Feb; 17(2):2479-2487. PubMed ID: 29207192
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy.
Yang J; Wang HX; Zhang YJ; Yang YH; Lu ML; Zhang J; Li ST; Zhang SP; Li G
J Ethnopharmacol; 2013 Dec; 150(3):1062-70. PubMed ID: 24432369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]